ReleaseWire

NASDAQ:ATNX Investor Notice: Deadline on May 3, 2021 in Lawsuit Athenex, Inc.

A Deadline is coming up on May 3, 2021 in the lawsuit for certain investors in Athenex, Inc. (NASDAQ:ATNX).

Posted: Tuesday, April 27, 2021 at 12:00 PM CDT

San Diego, CA -- (SBWire) -- 04/27/2021 --The Shareholders Foundation announced that a deadline is coming up on May 3, 2021 in the lawsuit filed for certain investors of Athenex, Inc. (NASDAQ: ATNX).

Investors who purchased shares of Athenex, Inc. (NASDAQ: ATNX) have certain options and there are strict and short deadlines running. Deadline: May 3, 2021. NASDAQ: ATNX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of Athenex, Inc. (NASDAQ: ATNX) common shares between August 7, 2019 and February 26, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 7, 2019 and February 26, 2021, the Defendants failed to disclose to investors that the data included in the Oral Paclitaxel plus Encequidar NDA presented a safety risk to patients in terms of an increase in neutropenia-related sequalae, that the uncertainty over the results of the primary endpoint of objective response rate (ORR) at week 19 conducted by BICR, that the BICR reconciliation and re-read process may have introduced unmeasured bias and influence on the BICR, that the Company's Phase 3 study that was used to file the NDA was inadequate and not well-conducted in a patient population with metastatic breast cancer representative of the U.S. population, such that the FDA would recommended a new such clinical trial, that as a result, it was foreseeable that the FDA would not approve the Company's NDA in its current form, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Athenex, Inc. (NASDAQ: ATNX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.